OXURION: Oxurion expands its capabilities to address the growing demand for GLP-1 and peptide clinical research services

Leuven, BELGIUM - June 2, 2026 - 18:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company based in Leuven, today announced the launch of a dedicated service offering focuse...